Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Report on Seborrheic Dermatitis Market Size & Share Worth USD 5 billion, to Record a 11.1% CAGR by 2030 | Seborrheic Dermatitis Industry Trends, Segmentation, Analysis & Forecast by FnF


NEW YORK, Feb. 1, 2023 /PRNewswire/ -- As per Facts and Factors study, The global seborrheic dermatitis market size was worth around USD 2.2 billion in 2021 and is predicted to grow to around USD 5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11.1% between 2022 and 2030.

FnF_Research_Logo

Seborrheic Dermatitis Market: Overview

Seborrheic dermatitis is a non-serious medical condition that does not cause significant harm to the infected person. It is an extremely common and non-contagious disease that can be managed with minimum care. Seborrheic dermatitis causes greasy scales and leads to itchy red patches. It appears as flaky, itchy, and dry skin on the scalp along with other body parts. Seborrheic is the reference for sebaceous glands and derm stands for the skin. In common terms, it is called dandruff if it occurs on the scalp of an adult. The same condition is called cradle cap if it occurs in a baby.

Dandruff is not limited only to the scalp but can occur on other body parts as well like the upper chest, upper back, creases at the base of the nose, forehead, face, navel area, eyebrows, behind the ears, under the breast and in bends or creases of legs, arms, and groin. The symptoms of the disease include the occurrence of itchy white flakes on the skin on the scalp. If the flakes are itched, they can become loose, fall on the neck area, and mix with hair. The condition also leads to red scales on the skin.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/seborrheic-dermatitis-market

Key Insights:

Facts and Factors published the latest report titled "Seborrheic Dermatitis Market Size, Share, Growth Analysis Report By Route Of Administration (Parenteral, Topical, Oral, and Others), By Treatment (Antifungal, Anti-Inflammatory, Sulfur Products, and Others), By End-Users (Speciality Clinics, Hospitals, Homecare, and Others), By Dosage Form (Shampoos, Creams, Gels, Ointments, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 ? 2030" into their research database.

Industry Dynamics:

Seborrheic Dermatitis Market: Growth Drivers

The global seborrheic dermatitis market is projected to grow owing to the high number of patients suffering from the condition on a regular basis across the globe. The medical concern is extremely common in adults. As per estimates, more than 11% of the world's population is infected by seborrheic dermatitis. It is mostly observed in infants that are below 3 months old or in adults between 30 to 60 years of age. Men are at higher risk than women and the rate of infection is higher in Caucasians as compared to African Americans. People who are born with naturally oily skin are more likely to contract the disease or if there is a history of psoriasis then the future generation becomes more vulnerable. Patients who have several other medical conditions are also more prone to seborrheic dermatitis. 

Seborrheic Dermatitis Market: Restraints

Even though the condition is extremely common and has long prevailed in the medical community, there is a lack of concrete treatment plan that has proven to be one hundred effective in treating the condition. Most of the plans can help manage the condition but not completely cure it. Most of the cure methods have to be customized as per the requirement and involve trial and error methods. The chances of the condition recurring are very high once the medication is switched or stopped.

Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/seborrheic-dermatitis-market

Global Seborrheic Dermatitis Market: Opportunities

Since seborrheic dermatitis is mostly seen in infants, the rapid rate at which the population is growing could lead to higher growth opportunities. The world population crossed the 8 billion mark on 15th November 2022. As per projections, the total population would cross the 10 billion mark by 2100.

As of 2020, the birth rate as per data from across the world is 2.39 births per woman. The other segment of the population that is more prone to the disease includes adults. As per the World Health Organization, the geriatric population was estimated to be around 253 million in 2010.

Global Seborrheic Dermatitis Market: Challenges

One of the major challenges for people suffering from seborrheic dermatitis is the reduced quality of life in patients. Since the condition starts appearing on the outer ski, it can greatly diminish the confidence level of the people suffering from it. This is also caused due to the negative advertisements and sentiments associated with the condition. Studies have concluded that dandruff in adults can be associated with embarrassment and self-consciousness. It is known to be the cause of more psychological problems than medical issues.

Global Seborrheic Dermatitis Market: Segmentation

Based on the route of administration, the global market is segmented as parenteral, topical, oral, and others. In 2021, the global market registered the highest growth in the topical segment since most of the medicines available in the market for the treatment of the condition are supposed to be applied externally. These medicines are available in various forms that have to be administered topically at regular intervals as recommended by the medical professional. The increasing number of topical product launches showing effective results could lead to further segmental growth. Topical ketoconazole is a popular choice. The medicine takes around 4 weeks to manage the medical problem.

Based on dosage form, the global market divisions are shampoos, creams, gels, ointments, and others. In 2021, the creams segment led the global market with the highest CAGR followed by ointments and shampoos. The latter is one of the most common methods of managing dandruff as there are specially curated hair-washing products including conditioners that claim to get rid of the condition with regular use.

However, they do not eradicate the diseases completely and the chances of the condition coming back remain high. These shampoos are recommended to be used 2 times a week for expected results.

Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/seborrheic-dermatitis-market

List of Key Players in Seborrheic Dermatitis Market:

Key questions answered in this report:

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 2.2 Billion

Revenue forecast in 2030

USD 5 Billion

Growth Rate

CAGR of almost 11.1 % 2022-2030

Base Year

2020

Historic Years

2016 ? 2021

Forecast Years

2022 ? 2030

Segments Covered

By Route Of Administration, Treatment, End-Users, Dosage Form, and Region

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2030

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Pfizer Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, Abbott, Teva Pharmaceutical Industries Ltd, and others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.  

https://www.fnfresearch.com/customization/seborrheic-dermatitis-market

 

 Free Brochure: https://www.fnfresearch.com/ask-to-analyst/seborrheic-dermatitis-market

Recent Developments

Regional Dominance:

The global seborrheic dermatitis market is projected to register the highest growth in North America mainly driven by the growing number of pharmaceutical companies in the US working consistently toward the development of new and improved medical treatments against the condition. As per estimates, one in every 5 Canadian citizens is known to suffer from dandruff which can be treated with over-the-counter shampoo. Over 50% of the North American population is estimated to suffer from the condition which means that the demand for the product is also high.

The regional market could further be driven by the already developed healthcare infrastructure of the countries. Around 38% of the American population has access to health insurance coverage in 2021 which was an increase of 1.21% from 2020. The growing initiatives undertaken by the medical community of the region to normalize the condition and help create support groups for people infected with the disease have encouraged a larger group of people to seek treatment.

Global Seborrheic Dermatitis Market is segmented as follows:

Seborrheic Dermatitis Market: By Route Of Administration Outlook (2022-2030)

Seborrheic Dermatitis Market: By Treatment Outlook (2022-2030)

Seborrheic Dermatitis Market: By End-Users Outlook (2022-2030)

Seborrheic Dermatitis Market: By Dosage Form Outlook (2022-2030)

Seborrheic Dermatitis Market: By Region Outlook (2022-2030)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Press Release for Seborrheic Dermatitis Market: https://www.fnfresearch.com/news/global-seborrheic-dermatitis-market 

Browse Other Related Research Reports from Facts and Factors

Browse through Facts and Factors's coverage of the Global Healthcare Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us?after all?if you do well, a little of the light shines on us.

Contact Us:

Facts and Factors 
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: [email protected]  
Website: https://www.fnfresearch.com/

Logo: https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg

SOURCE FnF Research


These press releases may also interest you

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...



News published on and distributed by: